Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: The TRASA trial

Archives of Cardiovascular Diseases

Volumn 104, Issue 8-9, 2011, Pages 444-449

  Cuisset, Thomas ^a   Franceschi, Frederic ^a   Prevot, Sébastien ^a   Ansaldi, Sébastien ^a   Habib, Gilbert ^a   Pankert, Mathieu ^a   Fourcade, Laurent ^b   Poyet, Raphael ^a   Bonnet, Jean Louis ^a   Quilici, Jacques ^a  

^a TIMONE HOSPITAL   (France)

^b LAVERAN MILITARY TEACHING HOSPITAL   (France)

Author keywords

Alcohol septal ablation; Hypertrophic obstructive cardiomyopathy; Interventional cardiology; Temporary pacing

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ABLATION THERAPY; AGED; ALCOHOL SEPTAL ABLATION; ARTICLE; CANNULATION; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; HEART PACING; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PACEMAKER; PATIENT SAFETY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VALIDATION PROCESS;

ABLATION TECHNIQUES; AGED; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; ETHANOL; FEASIBILITY STUDIES; FEMALE; FRANCE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; RADIAL ARTERY; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053183674     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2011.05.006     Document Type: Article

References (21)

1. B.J. Maron, M.S. Maron, and E.D. Wigle The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy J Am Coll Cardiol 54 2009 191 200
2. B.J. Maron, W.J. McKenna, and G.K. Danielson American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713 (Pubitemid 37383745)
3. S. Agarwal, E.M. Tuzcu, and M.Y. Desai Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy J Am Coll Cardiol 55 2010 823 834
4. M. Alam, H. Dokainish, and N.M. Lakkis Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis Eur Heart J 30 2009 1080 1087
5. R.A. Leonardi, E.P. Kransdorf, and D.L. Simel Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment Circ Cardiovasc Interv 3 2010 97 104
6. L. Faber, H. Seggewiss, and U. Gleichmann Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography Circulation 98 1998 2415 2421 (Pubitemid 28549785)
7. H. Kuhn, T. Lawrenz, and F. Lieder Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10-year experience Clin Res Cardiol 97 2008 234 243 (Pubitemid 351464524)
8. J. Veselka, R. Duchonova, and S. Prochazkova Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes Am J Cardiol 95 2005 675 678 (Pubitemid 40255269)
9. T. Lawrenz, F. Lieder, and M. Bartelsmeier Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 49 2007 2356 2363 (Pubitemid 46891717)
10. R. Poyet, J. Quilici, and T. Cuisset Delayed occurrence of complete heart block after ethanol septal ablation for hypertrophic obstructive cardiomyopathy Int J Cardiol 147 2011 e32 e34
11. P. Sorajja, U. Valeti, and R.A. Nishimura Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy Circulation 118 2008 131 139
12. U. Sigwart Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy Lancet 346 1995 211 214
13. T.R. Betts Regional survey of temporary transvenous pacing procedures and complications Postgrad Med J 79 2003 463 465
14. J.J. Murphy Current practice and complications of temporary transvenous cardiac pacing BMJ 312 1996 1134 (Pubitemid 26131294)
15. V. Barriales Alvarez, J.A. Alvarez Tamargo, and M. Garcia Aguado Delayed myocardial perforation following pacemaker implantation Int J Cardiol 93 2004 89 91 (Pubitemid 38068520)
16. F. Kiemeneij, G.J. Laarman, and E. de Melker Transradial artery coronary angioplasty Am Heart J 129 1995 1 7
17. S.S. Jolly, S. Amlani, and M. Hamon Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
18. J.W. Eikelboom, S.R. Mehta, and S.S. Anand Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)
19. S.V. Rao, K. O'Grady, and K.S. Pieper Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206 (Pubitemid 41505393)
20. C.J. Cooper, R.A. El-Shiekh, and D.J. Cohen Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison Am Heart J 138 1999 430 436 (Pubitemid 29428763)
21. D.J. Cohen Outpatient transradial coronary stenting: implications for cost-effectiveness J Invasive Cardiol 8 Suppl. D 1996 36D 39D (Pubitemid 126736696)